SANDOZ EVEROLIMUS

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 1d7bb17d78e7ae14
Drug Approval Canada Name: SANDOZ EVEROLIMUS
Product Name: SANDOZ EVEROLIMUS
Status: Marketed
Status Date: 2020-09-17
Original Market Date: 2020-09-17
Din: 02492911
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AH02 EVEROLIMUS
Atc Name: l 04 ah 02
Aig Number: 0152682003
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

EVEROLIMUS

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1d7bb17d78e7ae14

Type

Standard